López VJI, Mendoza LS, Solís BM, Solís SJ, Dorador GVS

Language: Spanish
References: 19
Page: 7-13
PDF size: 328.36 Kb.

ABSTRACT

Introduction: in Mexico, sepsis, ischemic heart disease and ketoacidosis are the most common causes of ICU admittance without further knowledge about other related epidemiological data. Objective: analyze causes of admittance and mortality in a second level of care ICU. Material and methods: retrospective study of adult patients admitted to ICU between January 2011 and December 2021. COVID-19 and nonbeneficial treatment discharged patients were excluded. The sample was divided in two according to type of discharge: improvement or death. Demographic, comorbidities, complication and ICU procedures were the variables analyzed. A multivariate analysis was conducted to identify factors most associated with death. Results: 2,211 patients were evaluated (431 deaths, 19.4% mortality). Myocardial infarction, pneumonia and traumatic brain injury were the most common causes of death. 43% of patients were admitted by emergency services, 54% had medical conditions, with a mean age of 40 ± 16 years, 55% were woman. Intracranial hypertension increased the risk of death by 11.69 (95%CI 7.03-19.44, p < 0.0001), followed by shock and mechanical ventilation. Conclusion: in a second level of care ICU, myocardial infarction, pneumonia and traumatic head injury were the most frequent causes of death.

REFERENCES

1. Sandoval-Gutiérrez JL. Proyección en el sector salud 2018-2024. Rev Med Inst Mex Seguro Soc. 2020;58(2):80-83.

2. González-Sanginés B. En perspectiva y prospectiva de la pandemia. ¿Cuántas camas hay en los hospitales de México? Pluralidad y Consenso. 2020;10(44):62-67.

3. Rojas-Valdés RI. Evaluación de la efectividad de las medidas de mitigación para aplanar la curva epidemiológica de la COVID-19: evidencia de cinco ciudades de México. Denarius. 2021;40:69-89.

4. Carrillo-Esper R, Carrillo-Córdova JR, Carrillo-Córdova LD. Estudio epidemiológico de la sepsis en unidades de terapia intensiva mexicanas. Cir Ciruj. 2009;77:301-308.

5. Groeger JS, Guntunpalli K, Strosberg M, Halpern N, Raphaely RC, Cerra F, et al. Descriptive analysis of critical care units in the United States. Patient characteristics and intensive care utilization. Crit Care Med. 1993;21(2):279-291.

6. Sánchez-Velázquez LD, Martínez-Gutiérrez MA, Baltazar-Torres JA, Martínez-Soto J, Valencia-Escobar F, Mercado-Aguirre A, et al. Análisis de costos en las unidades de terapia intensiva mexicanas. Estudio multicéntrico. Rev Asoc Mex Med Crit y Ter Int. 2010;24(2):159-166.

7. Pronovost PJ, Jenckes MW, Dorman T, Garret E, Breslow MJ, Rosenfeld BA, et al. Organizational characteristics of intensive care units related to outcomes of abdominal aortic surgery. JAMA. 1999;281(14):1319-1317.

8. Luna-Contreras M, Muños JA, Freyermuth-Enciso G. Mortalidad materna en México, indicadores 2016. Ciudad de México: Observatorio Nacional Mortalidad Materna de México; 2018. pp. 1-151.

9. Freyermuth-Enciso MG, Luna-Contreras M. Muerte materna y muertes evitables en exceso. Propuesta metodológica para evaluar la política pública en salud. Revista Internacional de Estadística y Geografía. 2014;5(3):34-43.

10. Organización Panamericana de la Salud. La estandarización: un método epidemiológico clásico para la comparación de tasas. Boletín Epidemiológico (OPS). 2002;23(3):9-12.

11. Nates JL, Nunnally M, Kleinpell R, Blosser S, Goldner J, Birriel B, et al. ICU admission, discharge, and triage guidelines: a framework to enhance clinical operations, development of institutional policies, and further research. Crit Care Med. 2016;44(8):1553-1602.

12. Escamilla-Núñez MC, Castro-Porras L, Romero-Martínez M, Zárate-Rojas E, Rojas-Martínez R. Detección, diagnóstico previo y tratamiento de enfermedades crónicas no transmisibles en adultos mexicanos. Salud Pública Mex. 2023;65(Supl 1):S153-S162.

13. López-Valdés JI, Solis-Barraza M. Infarto agudo de miocardio en una unidad de segundo nivel. Rev Med Inst Mex Seguro Soc. 2020;58(3):275-283.

14. Hoste Eric A, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607-625.

15. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-789.

16. Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):775-787.

17. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287-1296.

18. Hendrickson KW, Peltan ID, Brown SM. The epidemiology of acute respiratory distress syndrome before and after coronavirus disease 2019. Crit Care Clin. 2021;37:703-716.

19. López-Valdés JI, Ponce-Mendoza RA, Solís-Barraza M, Trevizo-Díaz JL, Nevárez-Campos JR. Características clínicas asociadas a mortalidad por COVI-19 en cuidados intensivos. Rev Med Inst Mex Seguro Soc. 2022;60(3):249-257.